| 前收市價 | 64.25 |
| 開市 | 64.29 |
| 買盤 | 62.97 x 100 |
| 賣出價 | 63.08 x 100 |
| 今日波幅 | 62.65 - 64.29 |
| 52 週波幅 | 32.06 - 89.39 |
| 成交量 | |
| 平均成交量 | 455,751 |
| 市值 | 4.04B |
| Beta 值 (5 年，每月) | 1.30 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.17 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 101.50 |
Barrons.comARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
RA Capital increased its stake in biopharmaceutical firm ARS. Bain Capital lowered its stake in pharmaceutical firm Nuvalent.
Insider Monkey13 Best Short Squeeze Stocks To Buy Now
In this piece, we will take a look at the 13 best short squeeze stocks to buy now. If you want to skip our primer on short squeezing, and some of the greatest short squeezes in history, then you can take a look at the 5 Best Short Squeeze Stocks To Buy Now. Short selling is […]
InvestorPlace7 Biotech Stocks to Get In Now Before Investors Catch On
Biotechnology is the source of some of our strongest and growing revolutions. Gene technology allows us to cure incurable diseases and make miracles happen with living organisms. Immunotherapies promise targeted treatment without harmful side effects. And more and more, we are understanding the deep structure of cancers, allowing us to develop treatments that promise a cure, not just remission. This has led to the rise of biotech stocks to buy. However, the biotechnology sector has not yet reape
